SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (88)2/16/2000 10:09:00 PM
From: LLCF  Respond to of 447
 
HGSI, INCY, CRGN, and the rest look out, here comes OSIP!

<''This agreement represents the second part of a strategy to assemble a leading position with respect to both intellectual property and expertise for the use of these powerful yeast based technologies,'' stated Colin Goddard, Ph.D., President and Chief Executive Officer of OSI Pharmaceuticals, Inc. ''The Human Genome Project has created a wealth of information which, with functional genomics technologies such as these, can be turned into valuable knowledge in the form of validated and proprietary drug targets.''>

"I love the smell of genome in the morning"- DAK

DAK



To: Miljenko Zuanic who wrote (88)2/16/2000 11:06:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 447
 
>> PS: I am bit sad that OSIP franchise is from KDUS misfortune, but I guess this is how game work. <<

Agreed. However, look at what Woler is doing to save KDUS. Under the circumstances, lots of jobs were saved, and long-term investors will be well-served. I feel pretty good about it.

Masterful job by Woler under very difficult circumstances.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News